Statins for secondary prevention: might less in fact be more?

Nat Rev Endocrinol. 2011 Mar;7(3):131-2. doi: 10.1038/nrendo.2011.17. Epub 2011 Feb 1.
No abstract available

Publication types

  • News

MeSH terms

  • Humans
  • Hydroxymethylglutaryl-CoA Reductase Inhibitors / administration & dosage
  • Hydroxymethylglutaryl-CoA Reductase Inhibitors / adverse effects
  • Hydroxymethylglutaryl-CoA Reductase Inhibitors / therapeutic use*
  • Secondary Prevention / methods*

Substances

  • Hydroxymethylglutaryl-CoA Reductase Inhibitors